FAKTOR-OPTIONSSCHEIN - BAYER | Market Closed - Deutsche Boerse AG 15:40:40 2024-05-17 EDT | ||
| 24.44 EUR | +8.53% |
|
| Current month | -35.38% | ||
| 1 month | -58.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 24.44 | +8.53% |
| 24-05-16 | 22.52 | +10.72% |
| 24-05-15 | 20.34 | +14.01% |
| 24-05-14 | 17.84 | -11.29% |
| 24-05-13 | 20.11 | -11.72% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 03:40 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
Société Générale
|
| WKN | SN2T11 |
| ISIN | DE000SN2T117 |
| Date issued | 2022-06-02 |
| Strike | 66.63 € |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 97.42 € |
|---|---|
| Lowest since issue | 1.16 € |
| Spread | 0.36 € |
| Spread % | 1.44% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.58
EUR
Average target price
36.9
EUR
Spread / Average Target
+29.13%
- Stock Market
- Certificates
- Certificat
